Table 2. Characteristics of included studies for S. mekongi.
SL | Country (reference) | Study design | Study year | Total sample size | Participant’s age | Prior treatment with PZQ before | Index test | Reference standard |
---|---|---|---|---|---|---|---|---|
1 | Laos[35] | Cross sectional study | 2011–2012 | 234 | 2–77 years | ELISA | Kato-Katz | |
2 | Laos[36] | Cross-sectional survey | 2006 | 485 | > = 6 months | FECT | Kato-Katz |
Note: ELISA-Enzyme-Linked immuno sorbent assay; FECT-Formol-ethyl acetate sedimentation concentration technique.